Sustained weight loss after gastric banding revision for pouch-related problems

MM Beitner; CJ Ren-Fielding; MS Kurian; BF Schwack; AR Skandarajah; BN Thomson; AR Baxter; HL Pachter; GA Fielding

Journal article

Sustained weight loss after gastric banding revision for pouch-related problems

MM Beitner, CJ Ren-Fielding, MS Kurian, BF Schwack, AR Skandarajah, BN Thomson, AR Baxter, HL Pachter, GA Fielding

Annals of Surgery | LIPPINCOTT WILLIAMS & WILKINS | Published : 2014

DOI: 10.1097/SLA.0000000000000327

Abstract

OBJECTIVE:: To assess the impact of revisional surgery after laparoscopic adjustable gastric banding (LAGB) on weight loss at 12 and 24 months. BACKGROUND:: There is no uniform consensus as to the optimal procedure for patients requiring revision after LAGB. Few studies address the issue of weight loss after band salvage procedures, despite this being a critical factor in deciding which reoperative procedure to choose. METHODS:: A retrospective analysis was conducted of adult patients who underwent LAGB from January 1, 2001 to June 30, 2009 at a single institution. Patients who required revision for pouch-related problems including band slippage, pouch dilation, and hiatal hernia were studie..

View full abstract

University of Melbourne Researchers

Anita Skandarajah Author

Ben Thomson Author

Grants

Funding Acknowledgements

Dr. Fielding currently receives payment from Allergan, Inc. for lectures unrelated to this study. He has previously acted as a consultant for Allergan, Inc. and has appeared on a TV commercial for the Allergan, Inc. LAP-BAND (R). Dr. Ren-Fielding is a current board member and consultant for Allergan, Inc. She holds a grant from Allergan, Inc. for unrelated work and receives funding for lectures and meeting expenses. She has previously been a board member for ExploraMed and consultant for CAVU Medical, Inc. Dr. Kurian has previously received an honorarium from Allergan, Inc, for teaching unrelated to this study. Dr. Schwack receives an honorarium from Allergan, Inc, unrelated to this study. and has previously received funding for travel expenses from Allergan, Inc. and Ethicon Endo-Surgery, Inc. Thomson currently receives payment from Novartis Oncology for lectures unrelated to this study and has previously received funding for meeting expenses from Novartis Oncology. The authors declare no conflicts of interest.